Vantive Healthcare is a newly independent vital organ therapy company built on decades of leadership in kidney care innovation. We are committed to advancing our mission to extend lives and expand possibilities by empowering the patients, families and clinical teams we serve throughout the care process. Our journey began 70 years ago when we produced the first commercially available dialysis system. We introduced peritoneal dialysis (PD) for patients at home and have transformed both continuous renal replacement therapy (CRRT) in the ICU setting and hemodialysis (HD) delivered in a clinic setting. Over the years, we have relentlessly advanced these therapies with innovative products, integrated digital solutions and services aimed at saving and extending lives and improving patient quality of life. Now we are deepening our commitment to elevating the dialysis experience through digital solutions and advance service while evolving our organ support therapies beyond kidney care.
U.S. Renal Care
Dialysis service provider.
SUBMED
SUBMED, Delivering Innovative Dialysis Solutions for Improved Patient Outcomes SUBMED is a leading European manufacturer of high-quality dialysis kits and accessories. With over two decades of experience in the renal care industry, the company has established itself as a trusted partner for healthcare providers across the continent. Core Capabilities: Dialysis Kits: SUBMED’s comprehensive portfolio includes a wide range of dialysis kits for hemodialysis, peritoneal dialysis, and home-based dialysis therapies. These kits are designed to ensure patient safety, comfort, and clinical efficacy. Dialysis Accessories: In addition to its core dialysis kits, SUBMED offers a selection of complementary accessories, such as tubing sets, filters, and monitoring devices, to provide healthcare facilities with a one-stop-shop solution. Research and Development: SUBMED’s in-house R&D team is dedicated to continuously improving its product offerings, incorporating the latest advancements.
NIKKISO CO., LTD.
As a pioneer of dialysis machines, Nikkiso has been moving forward with the development of Hemodialysis . In order to propose a comfortable therapeutic environment for everyone who requires Hemodialysis, operations from development, manufacturing and sales, to maintenance are performed consistently at the Nikkiso Group. | We bring over a century of combined expertise to provide advanced solutions for cryogenic applications. Our portfolio includes centrifugal, reciprocating, and submerged motor pumps, along with a wide range of other specialized cryogenic equipment, all designed to deliver reliability and innovation. Our pumps are designed to handle a wide range of liquefied gases, including LNG, LPG, LNH3, LH2, CO2, C2H4, C3H8, C4H10, and more. We proudly serve diverse business segments including marine, transportation, power generation, industrial gas, clean energy, oil, and gas. With a legacy of engineering excellence and a focus on continuous improvement, Nikkiso is the trusted name in cryogenic pump technology worldwide.
JMS NORTH AMERICA
JMS, a global leader in medical devices, introduces two innovative solutions to support healthcare professionals and improve the quality of life for patients with swallowing disorders. Peco Panda is a self-training device that helps increase tongue pressure—essential for safe swallowing. Its friendly design makes it ideal for children but also effective for elderly care. It promotes safe tongue exercises that strengthen muscles and support dysphagia rehabilitation. The Tongue Pressure Measurement Device allows accurate evaluation of tongue strength, providing key data for clinical management of dysphagia across various therapeutic settings. | JMS is a global manufacturer and supplier of Medical Devices used for Infusion and Transfusion, Dialysis, Cardiovascular Therapies and General Medical Supplies.
ISPD – International Society for Peritoneal Dialysis
The International Society for Peritoneal Dialysis aims to increase the global uptake, promote quality practice, and achieve optimal outcomes of peritoneal dialysis through enhanced advocacy, research, and education, in order to improve the health and well-being of people living with end-stage kidney disease or suffering from acute kidney injury.
Innovative Renal Care
Innovative Renal Care (IRC) is the trusted expert and preferred dialysis partner among physicians, acute, and post-acute providers for support of chronic kidney disease (CKD) and the care of end-stage renal disease (ESRD). Providing coordinated, comprehensive services throughout the care continuum, we support patients, physicians, and healthcare partners by delivering services where and when they need them. Developing and offering cutting-edge tools like our InnovAItive AI platform, we empower professionals with invaluable insights for patient care and treatment planning, leading to exceptional clinical outcomes.
Fresenius Medical Care
Creating a future worth living. For patients. Worldwide. Every day. Fresenius Medical Care is a leading provider of healthcare products and services for chronically and critically ill patients across the kidney care continuum and beyond. Grounded in research and advocacy, we aim to elevate care, improve outcomes, and enhance the patient experience. Our connected approach brings consistency and compassion in every stage of the dialysis pathway – at home, in-center or hospitals.
DaVita Kidney Care
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2025, DaVita served approximately 282,000 patients at 3,173 outpatient dialysis centers, of which 2,661 centers were located in the United States and 512 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
CorMedix Therapeutics
Melinta Therapeutics provides innovative therapies to people impacted by acute and life-threatening illnesses. Our portfolio currently includes seven commercial-stage products. With an unsurpassed commitment to providers and the patients they serve, we work to ensure that all people who need our therapies can receive them. We focus our expanding portfolio on serving patients with an unmet need because that’s how we make the most meaningful impact. At Melinta, we’re visionaries dedicated to innovation while staying grounded in what matters most: patients. Visit www.melinta.com for more information. | At CorMedix Therapeutics, we’re driven to protect vulnerable patients from serious, life-threatening infections. With eight commercial-stage products spanning prevention and treatment, we address critical, unmet needs across multiple care settings. Our dedicated team is committed to ensuring access to our therapies and to continuously expanding our portfolio to improve patient outcomes. Discover more at www.cormedix.com